Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 13 2025
Sep, 25 2025
Dec, 17 2025
Jul, 20 2026
Dec, 7 2024